Literature DB >> 28272906

Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.

Britney A Helling1, Anthony N Gerber1,2, Vineela Kadiyala2, Sarah K Sasse2, Brent S Pedersen1, Lenore Sparks1, Yasushi Nakano1, Tsukasa Okamoto1, Christopher M Evans1, Ivana V Yang1,3, David A Schwartz1,2.   

Abstract

The gain-of-function mucin 5B (MUC5B) promoter variant, rs35705950, confers the largest risk, genetic or otherwise, for the development of idiopathic pulmonary fibrosis; however, the mechanisms underlying the regulation of MUC5B expression have yet to be elucidated. Here, we identify a critical regulatory domain that contains the MUC5B promoter variant and has a highly conserved forkhead box protein A2 (FOXA2) binding motif. This region is differentially methylated in association with idiopathic pulmonary fibrosis, MUC5B expression, and rs35705950. In addition, we show that this locus binds FOXA2 dynamically, and that binding of FOXA2 is necessary for enhanced expression of MUC5B. In aggregate, our findings identify novel targets to regulate the expression of MUC5B.

Entities:  

Keywords:  DNA methylation; gene regulation; idiopathic pulmonary fibrosis; mucin 5B; mucins

Mesh:

Substances:

Year:  2017        PMID: 28272906      PMCID: PMC5516283          DOI: 10.1165/rcmb.2017-0046OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly.

Authors:  Shireen A Sarraf; Irina Stancheva
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

3.  MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.

Authors:  Yasushi Nakano; Ivana V Yang; Avram D Walts; Alan M Watson; Britney A Helling; Ashley A Fletcher; Abigail R Lara; Marvin I Schwarz; Christopher M Evans; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 4.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 5.  Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.

Authors:  Richard C Boucher
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

6.  Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.

Authors:  Martina Korfei; Sylwia Skwarna; Ingrid Henneke; BreAnne MacKenzie; Oleksiy Klymenko; Shigeki Saito; Clemens Ruppert; Daniel von der Beck; Poornima Mahavadi; Walter Klepetko; Saverio Bellusci; Bruno Crestani; Soni Savai Pullamsetti; Ludger Fink; Werner Seeger; Oliver Holger Krämer; Andreas Guenther
Journal:  Thorax       Date:  2015-09-10       Impact factor: 9.139

7.  A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis.

Authors:  Yingze Zhang; Imre Noth; Joe G N Garcia; Naftali Kaminski
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

8.  Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins.

Authors:  Yonghua Hao; Zhizhou Kuang; Jia Jing; Jinfeng Miao; Li Yu Mei; Ryan J Lee; Susie Kim; Shawn Choe; Duncan C Krause; Gee W Lau
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

9.  The relationship of DNA methylation with age, gender and genotype in twins and healthy controls.

Authors:  Marco P Boks; Eske M Derks; Daniel J Weisenberger; Erik Strengman; Esther Janson; Iris E Sommer; René S Kahn; Roel A Ophoff
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

10.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330

View more
  33 in total

1.  Understanding Interstitial Lung Disease: It's in the Mucus.

Authors:  Burton F Dickey; Jeffrey A Whitsett
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

2.  XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.

Authors:  Gang Chen; Carla M P Ribeiro; Ling Sun; Kenichi Okuda; Takafumi Kato; Rodney C Gilmore; Mary B Martino; Hong Dang; Aiman Abzhanova; Jennifer M Lin; Emily A Hull-Ryde; Allison S Volmer; Scott H Randell; Alessandra Livraghi-Butrico; Yingfeng Deng; Philipp E Scherer; Barry R Stripp; Wanda K O'Neal; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 3.  Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

Review 4.  Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.

Authors:  Tara V Saco; Mason T Breitzig; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-03       Impact factor: 6.914

Review 5.  Lung microbial-host interface through the lens of multi-omics.

Authors:  Shivani Singh; Jake G Natalini; Leopoldo N Segal
Journal:  Mucosal Immunol       Date:  2022-07-06       Impact factor: 8.701

6.  MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Authors:  Pierre-Antoine Juge; Joyce S Lee; Esther Ebstein; Hiroshi Furukawa; Evgenia Dobrinskikh; Steven Gazal; Caroline Kannengiesser; Sébastien Ottaviani; Shomi Oka; Shigeto Tohma; Naoyuki Tsuchiya; Jorge Rojas-Serrano; Montserrat I González-Pérez; Mayra Mejía; Ivette Buendía-Roldán; Ramcés Falfán-Valencia; Enrique Ambrocio-Ortiz; Effrosyni Manali; Spyros A Papiris; Theofanis Karageorgas; Dimitrios Boumpas; Katarina Antoniou; Coline H M van Moorsel; Joanne van der Vis; Yaël A de Man; Jan C Grutters; Yaping Wang; Raphaël Borie; Lidwine Wemeau-Stervinou; Benoît Wallaert; René-Marc Flipo; Hilario Nunes; Dominique Valeyre; Nathalie Saidenberg-Kermanac'h; Marie-Christophe Boissier; Sylvain Marchand-Adam; Aline Frazier; Pascal Richette; Yannick Allanore; Jean Sibilia; Claire Dromer; Christophe Richez; Thierry Schaeverbeke; Huguette Lioté; Gabriel Thabut; Nadia Nathan; Serge Amselem; Martin Soubrier; Vincent Cottin; Annick Clément; Kevin Deane; Avram D Walts; Tasha Fingerlin; Aryeh Fischer; Jay H Ryu; Eric L Matteson; Timothy B Niewold; Deborah Assayag; Andrew Gross; Paul Wolters; Marvin I Schwarz; Michael Holers; Joshua J Solomon; Tracy Doyle; Ivan O Rosas; Cornelis Blauwendraat; Mike A Nalls; Marie-Pierre Debray; Catherine Boileau; Bruno Crestani; David A Schwartz; Philippe Dieudé
Journal:  N Engl J Med       Date:  2018-10-20       Impact factor: 91.245

Review 7.  Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.

Authors:  Yujie Dai; Weina Wang; Yikai Yu; Shaoxian Hu
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

8.  High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling.

Authors:  Keith A Strand; Sizhao Lu; Marie F Mutryn; Linfeng Li; Qiong Zhou; Blake T Enyart; Austin J Jolly; Allison M Dubner; Karen S Moulton; Raphael A Nemenoff; Keith A Koch; Daniel V LaBarbera; Mary C M Weiser-Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-25       Impact factor: 8.311

9.  Citrullinated vimentin mediates development and progression of lung fibrosis.

Authors:  Fu Jun Li; Ranu Surolia; Huashi Li; Zheng Wang; Gang Liu; Tejaswini Kulkarni; Adriana V F Massicano; James A Mobley; Santanu Mondal; Joao A de Andrade; Scott A Coonrod; Paul R Thompson; Keith Wille; Suzanne E Lapi; Mohammad Athar; Victor J Thannickal; A Brent Carter; Veena B Antony
Journal:  Sci Transl Med       Date:  2021-03-17       Impact factor: 17.956

Review 10.  The Association between MUC5B Rs35705950 and Risks of Idiopathic Interstitial Pneumonia, Systemic Sclerosis Interstitial Lung Disease, and Familial Interstitial Pneumonia: A Meta-Analysis.

Authors:  Huai-Qing Lou; Chun-Xia Huang; Guang-Yi Li; Ping Li; Shou-Ming Zhang; Hai-Gang Li; Li Han; Mei-Hua Bao
Journal:  Iran J Public Health       Date:  2020-12       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.